n(2)-l-alanine l-glutamine dipeptide
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01478126)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Alanine aminotransferaseSUBSTRATE
GPT substrate
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- n(2)-l-alanine l-glutamine dipeptide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03341169 | N/A | Mar 20, 2018 | Yonsei University |
| NCT01478126 | Phase 3 | Jan 1, 2012 | Moscow State University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Moscow State University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Yonsei University | Academic/Hospital | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1